These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 16355882

  • 21. [Friend or foe: combination therapy with inhaled corticosteroids and long-acting beta2-agonists in chronic obstructive pulmonary disease (COPD)].
    Gillissen A, Gessner C, Hoheisel G, Juergens U.
    Pneumologie; 2008 Jul; 62(7):430-7. PubMed ID: 18398787
    [Abstract] [Full Text] [Related]

  • 22. [Inhaled corticosteroids in COPD--between pro and con?].
    Mihalţan F.
    Pneumologia; 2009 Jul; 58(4):204-5. PubMed ID: 20067052
    [No Abstract] [Full Text] [Related]

  • 23. Do inhaled corticosteroids slow FEV1 decline in COPD after all?
    Duerden MG.
    Thorax; 2004 Jun; 59(6):538-9; author reply 539-40. PubMed ID: 15170045
    [No Abstract] [Full Text] [Related]

  • 24. Ethics of placebo controlled studies of inhaled steroids for COPD.
    Hahn DL.
    Thorax; 2004 Jun; 59(6):539; author reply 539-40. PubMed ID: 15170046
    [No Abstract] [Full Text] [Related]

  • 25. Inhaled corticosteroids in obstructive airway disease.
    Phua GC, Macintyre NR.
    Respir Care; 2007 Jul; 52(7):852-8. PubMed ID: 17594729
    [Abstract] [Full Text] [Related]

  • 26. [Inhaled steroids in COPD. Do they modify the disease?].
    Welte T, Gillissen A.
    MMW Fortschr Med; 2002 Apr 11; 144(15):39-41. PubMed ID: 12004448
    [Abstract] [Full Text] [Related]

  • 27. Impact of regular inhaled corticosteroid use on chronic obstructive pulmonary disease outcomes.
    Vollmer WM, Peters D, Crane B, Kelleher C, Buist AS.
    COPD; 2007 Jun 11; 4(2):135-42. PubMed ID: 17530507
    [Abstract] [Full Text] [Related]

  • 28. Clinical course of chronic obstructive pulmonary disease: review of therapeutic interventions.
    Anzueto A.
    Am J Med; 2006 Oct 11; 119(10 Suppl 1):46-53. PubMed ID: 16996899
    [Abstract] [Full Text] [Related]

  • 29. Management of chronic obstructive pulmonary disease: moving beyond the asthma algorithm.
    Gordon E, Lazarus SC.
    J Allergy Clin Immunol; 2009 Nov 11; 124(5):873-80; quiz 881-2. PubMed ID: 19895979
    [Abstract] [Full Text] [Related]

  • 30. Inhaled corticosteroids and mortality in COPD.
    Sin DD, ISEEC Steering Commitee.
    Thorax; 2006 Oct 11; 61(10):918. PubMed ID: 17063568
    [No Abstract] [Full Text] [Related]

  • 31. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease.
    Lee TA, Wilke C, Joo M, Stroupe KT, Krishnan JA, Schumock GT, Pickard AS.
    Arch Intern Med; 2009 Aug 10; 169(15):1403-10. PubMed ID: 19667304
    [Abstract] [Full Text] [Related]

  • 32. Incident pneumonia and mortality in patients with chronic obstructive pulmonary disease. A double effect of inhaled corticosteroids?
    Festic E, Scanlon PD.
    Am J Respir Crit Care Med; 2015 Jan 15; 191(2):141-8. PubMed ID: 25409118
    [Abstract] [Full Text] [Related]

  • 33. Inhaled corticosteroids in COPD and mortality: inaccuracies?
    Suissa S.
    Am J Respir Crit Care Med; 2004 May 15; 169(10):1165-6; author reply 1166. PubMed ID: 15132963
    [No Abstract] [Full Text] [Related]

  • 34. Cost-effectiveness of inhaled corticosteroids in chronic obstructive pulmonary disease.
    Lee TA, Weiss KB, Sullivan SD.
    Am J Med; 2004 Oct 15; 117(8):618; author reply 618-9. PubMed ID: 15465515
    [No Abstract] [Full Text] [Related]

  • 35. Inhaled corticosteroids in COPD: a light at the end of the tunnel?
    Wedzicha JA, Seemungal TA.
    Thorax; 2005 Dec 15; 60(12):977-8. PubMed ID: 16299110
    [No Abstract] [Full Text] [Related]

  • 36. Alveolar-capillary membrane permeability for early prediction of response of inhaled steroid on patients with chronic obstructive pulmonary disease.
    Chou SH, Chen YW, Chuang HY, Kao EL, Huang MF.
    J Clin Pharm Ther; 2006 Aug 15; 31(4):363-8. PubMed ID: 16882106
    [Abstract] [Full Text] [Related]

  • 37. In-hospital mortality and long-term use of inhaled corticosteroids.
    Punnam SR.
    Arch Intern Med; 2004 Jan 26; 164(2):222; author reply 222-3. PubMed ID: 14744849
    [No Abstract] [Full Text] [Related]

  • 38. Clinical inquiries. What effect do inhaled steroids have on delaying the progression of COPD?
    Hansen L, Havemann J, Burroughs M, Lo V.
    J Fam Pract; 2004 Oct 26; 53(10):835-6. PubMed ID: 15469782
    [No Abstract] [Full Text] [Related]

  • 39. Optimizing treatment of chronic obstructive pulmonary disease: an assessment of current therapies.
    Wise RA, Tashkin DP.
    Am J Med; 2007 Aug 26; 120(8 Suppl 1):S4-13. PubMed ID: 17678942
    [Abstract] [Full Text] [Related]

  • 40. Survival among COPD patients using fluticasone/salmeterol in combination versus other inhaled steroids and bronchodilators alone.
    Mapel DW, Nelson LS, Lydick E, Soriano J, Yood MU, Davis KJ.
    COPD; 2007 Jun 26; 4(2):127-34. PubMed ID: 17530506
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.